Cargando…
Urokinase receptor and resistance to targeted anticancer agents
The urokinase receptor (uPAR) is a GPI-anchored membrane protein, which regulates protease activity at the cell surface and, in collaboration with a system of co-receptors, triggers cell-signaling and regulates gene expression within the cell. In normal tissues, uPAR gene expression is limited; howe...
Autores principales: | Gonias, Steven L., Hu, Jingjing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515545/ https://www.ncbi.nlm.nih.gov/pubmed/26283964 http://dx.doi.org/10.3389/fphar.2015.00154 |
Ejemplares similares
-
Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor
por: Zhu, Ran, et al.
Publicado: (2022) -
Mitochondrial-Targeting Anticancer Agent Conjugates and Nanocarrier Systems for Cancer Treatment
por: Battogtokh, Gantumur, et al.
Publicado: (2018) -
Menthol: An underestimated anticancer agent
por: Zhao, Yijia, et al.
Publicado: (2023) -
Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator Receptor
por: Rotbain Curovic, Viktor, et al.
Publicado: (2022) -
Selective Acetogenins and Their Potential as Anticancer Agents
por: Jacobo-Herrera, Nadia, et al.
Publicado: (2019)